Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Appendix B: Panel Roster and Financial Disclosures

CAP

Last Updated: August 1, 2019; Last Reviewed: August 1, 2019

Community-Acquired Pneumonia
Member Financial Disclosure
Company Relationship
Cribbs, Shushma
Emory University NIH Research Support
Crothers, Kristina* University of Washington American Lung Association Research Support
NIH Honoraria
Matanock, Almea Centers for Disease Control and Prevention Gavi, The Vaccine Alliance Research Support
Miller, Robert University College London, England Gilead Honoraria, Speaker’s Bureau
British HIV Association Research Support
Niederman, Michael Cornell University Bayer Advisory Board, Research Support
Merck Advisory Board, Research Support
Partek Advisory Board
Pfizer Advisory Board
Shionogi Advisory Board, Research Support
Rodriguez-Barradas, Maria Michael E. DeBakey VAMC and Baylor College of Medicine None N/A

* Group lead

Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Key:
CDC = Centers for Disease Control and Prevention; NIH = National Institutes of Health; N/A = not applicable

Download Guidelines